Schroder Investment Management Group lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 6,992 shares of the medical equipment provider’s stock after selling 3,419 shares during the quarter. Schroder Investment Management Group’s holdings in Intuitive Surgical were worth $4,014,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Arrow Financial Corp bought a new stake in shares of Intuitive Surgical in the third quarter worth $115,000. JNBA Financial Advisors bought a new stake in shares of Intuitive Surgical in the third quarter worth $115,000. Pendal Group Ltd bought a new stake in shares of Intuitive Surgical in the third quarter worth $118,000. Optimum Investment Advisors lifted its position in shares of Intuitive Surgical by 189.9% in the third quarter. Optimum Investment Advisors now owns 229 shares of the medical equipment provider’s stock worth $131,000 after purchasing an additional 150 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of Intuitive Surgical in the third quarter worth $137,000. 84.31% of the stock is currently owned by hedge funds and other institutional investors.
In other Intuitive Surgical news, COO Salvatore Brogna sold 2,090 shares of the company’s stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $541.88, for a total transaction of $1,132,529.20. Following the sale, the chief operating officer now directly owns 2,049 shares of the company’s stock, valued at $1,110,312.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 1,000 shares of the company’s stock in a transaction on Tuesday, October 23rd. The stock was sold at an average price of $500.00, for a total transaction of $500,000.00. Following the sale, the director now directly owns 9,874 shares in the company, valued at $4,937,000. The disclosure for this sale can be found here. Insiders have sold 72,491 shares of company stock worth $37,767,784 over the last ninety days. Insiders own 2.20% of the company’s stock.
ISRG has been the topic of a number of research reports. Piper Jaffray Companies boosted their price objective on shares of Intuitive Surgical from $613.00 to $625.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 31st. Cantor Fitzgerald reissued a “buy” rating and issued a $620.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 19th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $615.00 price objective on the stock in a research report on Wednesday. BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 22nd. Finally, BTIG Research reissued a “hold” rating on shares of Intuitive Surgical in a research report on Sunday, October 21st. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $556.01.
NASDAQ ISRG opened at $491.69 on Friday. Intuitive Surgical, Inc. has a 1 year low of $359.75 and a 1 year high of $581.12. The firm has a market cap of $59.28 billion, a price-to-earnings ratio of 68.39, a PEG ratio of 3.76 and a beta of 1.03.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.66 by $0.17. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The firm had revenue of $920.90 million for the quarter, compared to analyst estimates of $916.22 million. During the same period in the prior year, the firm posted $2.77 earnings per share. The company’s quarterly revenue was up 14.0% compared to the same quarter last year. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 9.52 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This story was published by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2018/12/08/schroder-investment-management-group-cuts-holdings-in-intuitive-surgical-inc-isrg.html.
Intuitive Surgical Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Featured Article: Diversification Important in Investing
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.